|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,415.00 GBX | +2.23% |
|
+2.06% | +4.35% |
| 09:52am | AstraZeneca Enters Multi-Year Genomics Agreement With Helix for Drug Discovery Research | MT |
| 09:28am | Alert incorrectly tagged to Helix Acquisition Corp III withdrawn | RE |
| Market Cap | 292B 256B 236B 219B 415B 27,860B 421B 2,820B 1,098B 13,676B 1,097B 1,073B 47,415B | P/E 2026 * |
23.5x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 311B 273B 251B 233B 443B 29,695B 449B 3,006B 1,170B 14,576B 1,169B 1,143B 50,538B | EV / Sales 2026 * |
4.93x | EV / Sales 2027 * | 4.54x |
| Free-Float |
96.63% | Yield 2026 * |
1.77% | Yield 2027 * | 1.87% |
Last Transcript: AstraZeneca PLC
| 1 day | +2.26% | ||
| 1 week | +2.06% | ||
| Current month | +2.06% | ||
| 1 month | +4.31% | ||
| 3 months | -3.80% | ||
| 6 months | +1.17% | ||
| Current year | +4.35% |
| 1 week | 13,838 |  | 14,686 |
| 1 month | 11,364 | | 15,126 |
| Current year | 11,232 | | 15,732 |
| 1 year | 10,148 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,029 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 07 | Free | See Remarks | 1 | 0.0000% | ||
| May. 19 | Sell | See Remarks | -11,893 | 0.0008% | ||
| May. 13 | Fiscal year | Chief Executive Officer | 18,359 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.23% | +2.06% | +40.83% | +42.33% | 292B | |
| +2.93% | +3.00% | +59.85% | +173.28% | 1,070B | |
| +3.67% | +5.64% | +72.80% | +68.48% | 624B | |
| +1.18% | +2.77% | +37.84% | +90.86% | 450B | |
| -0.65% | +0.53% | +31.00% | +25.82% | 328B | |
| +1.36% | +0.08% | +29.78% | +49.19% | 284B | |
| +2.02% | +4.02% | -25.83% | -39.06% | 217B | |
| +1.44% | +2.56% | +26.78% | +69.86% | 198B | |
| +4.26% | +7.17% | +21.13% | +81.94% | 161B | |
| +1.88% | +0.33% | -4.28% | -32.00% | 135B | |
| Average | +2.01% | +0.70% | +28.99% | +53.07% | 375.95B | |
| Weighted average by Cap. | +2.24% | +0.65% | +42.45% | +84.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.19B 55.35B 50.98B 47.32B 89.85B 6,028B 91.07B 610B 237B 2,959B 237B 232B 10,259B | 66.85B 58.55B 53.93B 50.06B 95.05B 6,377B 96.34B 646B 251B 3,130B 251B 246B 10,853B |
| Net income | 12.45B 10.91B 10.04B 9.32B 17.71B 1,188B 17.94B 120B 46.79B 583B 46.76B 45.74B 2,021B | 13.96B 12.23B 11.26B 10.45B 19.85B 1,332B 20.12B 135B 52.46B 654B 52.43B 51.28B 2,266B |
| Net Debt | 19.24B 16.85B 15.52B 14.4B 27.35B 1,835B 27.72B 186B 72.29B 901B 72.24B 70.65B 3,123B | 11.71B 10.26B 9.45B 8.77B 16.65B 1,117B 16.88B 113B 44.01B 548B 43.98B 43.01B 1,901B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | GBX 14,388.00 | +2.04% | 343,863 |
| 26-07-06 | GBX 14,100.00 | -2.46% | 2,008,204 |
| 26-07-03 | GBX 14,456.00 | -0.56% | 653,264 |
| 26-07-02 | GBX 14,538.00 | +4.94% | 2,810,574 |
| 26-07-01 | GBX 13,854.00 | -1.74% | 1,804,499 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
